On Sep 28, 2021 Kytopen closed a Series A round and raised $30,000,000 from Alexandria Venture Investments, Horizon Ventures, John Ballantyne, MassVentures, Michael Chambers, Northpond Ventures, The Engine, featuring lead investors Northpond Ventures.

About the company: Kytopen is located at United States, North America.
“Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.”

Company website: http://www.kytopen.com